[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07197801":3,"trial-entities:NCT07197801":84,"trial-summary:NCT07197801":87},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":6,"overall_status":7,"completion_date":8,"status_verified_date":9,"last_update_date":10,"start_date":11,"sponsor_name":12,"lead_sponsor_class":13,"has_dmc":14,"brief_summary":15,"detailed_description":16,"conditions":17,"keywords":19,"study_type":22,"primary_purpose":23,"phases":24,"enrollment_info":26,"interventions":29,"primary_outcomes":36,"secondary_outcomes":44,"sex":45,"minimum_age":46,"maximum_age":47,"healthy_volunteers":14,"eligibility_criteria":48,"std_ages":57,"locations":60,"central_contacts":73,"overall_officials":79,"references":82,"see_also_links":83},"NCT07197801","R33DA059880-02","Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment","RECRUITING","2029-07-31","2026-02","2026-02-18","2025-12-23","Geisinger Clinic","OTHER",false,"The goal of this clinical trial is to learn if receiving peer recovery support (support services provided by trained \"peers\" with lived experience of addiction and recovery) improves retention in medication treatment among people with opioid use disorder. The main question it aims to answer is: does peer recovery support improve retention in medication treatment for opioid use disorder?\n\nResearchers will compare two groups: (1) standard care combined with a peer recovery support program, and (2) standard care alone, to see if peer recovery support works to improve retention in medication treatment for opioid use disorder.\n\nParticipants will: visit clinics as they normally would to receive standard care (medication treatment for opioid use disorder); complete two questionnaires - one when they start treatment and one 6 months later; and agree to let researchers use information from their medical record. Participants in group 1 will also be invited to meet with a peer recovery support specialist for up to 6 months.",null,[18],"Opioid Use Disorder",[20,21],"Medication for opioid use disorder","Peer recovery support","INTERVENTIONAL","HEALTH_SERVICES_RESEARCH",[25],"NA",{"count":27,"type":28},218,"ESTIMATED",[30],{"type":31,"name":32,"description":33,"armGroupLabels":34},"BEHAVIORAL","Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment","The intervention adds a peer recovery support (PRS) program to standard outpatient medication for opioid use disorder treatment and medical care. The PRS program will entail meeting one-on-one with a peer recovery specialist over a 6-month period, who will utilize their lived experience with substance use and recovery to provide emotional, informational, instrumental, and affiliational support to participants.",[35],"Standard Care + Peer Recovery Support",[37,41],{"measure":38,"description":39,"timeFrame":40},"6-month treatment retention","Data will come from the electronic health records. Retention will be defined as a participant not having a lapse in days' supply of medication for opioid use disorder treatment (buprenorphine, buprenorphine-naloxone, or naltrexone) within the 6-month follow-up period that is greater than 30 days.","180 days from initiation of medication treatment for opioid use disorder",{"measure":42,"description":43,"timeFrame":40},"Length of time in treatment","Data will come from the electronic health records. Length of time in treatment will be determined by summing days' supply of consecutive orders for medications for opioid use disorder treatment(buprenorphine, buprenorphine- naloxone, or naltrexone). Treatment will be considered ended if a participant has a gap in supply of more than 30 days.",[],"ALL","18 Years","89 Years",{"inclusion":49,"exclusion":53,"raw_text":56},[50,51,52],"Adult ≥ 18 years of age","Initiated medication for opioid use disorder treatment in past 45 days in a Geisinger outpatient clinic","Willing and able to give informed consent",[54,55],"Received medication for opioid use disorder treatment at a Geisinger outpatient clinic in the 90-day period prior to the treatment initiation date","Not proficient in English","Inclusion Criteria:\n\n* Adult ≥ 18 years of age\n* Initiated medication for opioid use disorder treatment in past 45 days in a Geisinger outpatient clinic\n* Willing and able to give informed consent\n\nExclusion Criteria:\n\n* Received medication for opioid use disorder treatment at a Geisinger outpatient clinic in the 90-day period prior to the treatment initiation date\n* Not proficient in English",[58,59],"ADULT","OLDER_ADULT",[61],{"facility":12,"status":7,"city":62,"state":63,"zip":64,"country":65,"contacts":66,"geoPoint":70},"Danville","Pennsylvania","17822","United States",[67],{"name":68,"role":69},"Melissa N Poulsen, PhD, MPH","PRINCIPAL_INVESTIGATOR",{"lat":71,"lon":72},40.96342,-76.61273,[74],{"name":75,"role":76,"phone":77,"email":78},"Project Manager","CONTACT","1-866-910-6486, Option 3","PEERS@geisinger.edu",[80],{"name":81,"affiliation":12,"role":69},"Melissa Poulsen, PhD",[],[],{"nct_id":4,"conditions":85,"biomarkers":86},[18],[],{"nct_id":4,"found":88,"summary":89,"prompt_version":99},true,{"design":90,"status":91,"heading":92,"summary":93,"follow_up":94,"word_count":95,"commitments":96,"compensation":97,"drugs_mentioned":98},"This study plans to enroll 218 participants. It will compare two groups: one receiving standard care plus peer recovery support, and another receiving standard care alone.","completed","Peer Recovery Support for Opioid Use Disorder Treatment","This study is looking at whether adding peer recovery support (help from someone with their own experience of addiction and recovery) can help people stay in treatment for opioid use disorder. You might be able to join if you are 18 or older, have started medication for opioid use disorder in the last 45 days at a Geisinger clinic, and are willing to give informed consent. The study will compare people who receive standard care plus peer support to those who receive standard care alone. The main goal is to see if peer support helps people stay in treatment for 6 months.","The study will measure how long participants stay in treatment for up to 180 days (about 6 months) from when they started medication.",102,"If you join, you would meet one-on-one with a peer recovery specialist over a 6-month period.","Not stated in the trial record.",[],"v2"]